siRNA 화학물질, 링커, 시약 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

siRNA Chemical, Linkers and Reagents Market Summary

The global siRNA chemical, linkers & reagents market size was valued at USD 939.9 million in 2025 and is projected to grow from USD 1,028.5 million in 2026 to USD 2,593.2 million by 2033, at a CAGR of 14.1% from 2026 to 2033. North America dominated the global market with the largest revenue share of 41.2% in 2025. Growth is driven by rising adoption of siRNA therapeutics, increasing RNAi research activities, and growing demand for advanced oligonucleotide synthesis and delivery technologies.

Global siRNA Chemical, Linkers And Reagents Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global siRNA chemical, linkers and reagents market based on the type, application, end-use, and region:

• Type Scope Outlook (Revenue, USD Million, 2021 - 2033)
• siRNA Synthesis Chemicals
• Chemical Modifiers
• Linkers
• Conjugation Reagents
• Delivery-Related Reagents
• Others
• Application Scope Outlook (Revenue, USD Million, 2021 - 2033)
• Therapeutics Development
• Research & Discovery
• Drug Delivery Platform Development
• Others
• End-use Scope Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• CMOs / CDMOs
• Academic & Research Institutes
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Regional Scope
• 1.4. Estimates and Forecast Timeline
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Market Model
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations
• 1.12. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Clinical and Commercial Pipeline of siRNA Therapeutics
    • 3.2.1.2. Rising Adoption of GalNAc and Advanced Delivery Technologies
    • 3.2.1.3. Expansion of Oligonucleotide Manufacturing Capacity Globally
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost and Complexity of siRNA Manufacturing
    • 3.2.2.2. Stringent Regulatory and Quality Requirements
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Case Study Insights
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL Analysis

Chapter 4. Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. siRNA Chemical, Linkers & Reagents Market: Type Movement Analysis
• 4.3. siRNA Chemical, Linkers & Reagents Market Size & Trend Analysis, By Type, 2021 to 2033 (USD Million)
• 4.4. siRNA Synthesis Chemicals
  • 4.4.1. siRNA Synthesis Chemicals Market, 2021 - 2033 (USD Million)
• 4.5. Chemical Modifiers
  • 4.5.1. Chemical Modifiers Market, 2021 - 2033 (USD Million)
• 4.6. Linkers
  • 4.6.1. Linkers Market, 2021 - 2033 (USD Million)
• 4.7. Conjugation Reagents
  • 4.7.1. Conjugation Reagents Market, 2021 - 2033 (USD Million)
• 4.8. Delivery-Related Reagents
  • 4.8.1. Delivery-Related Reagents Market, 2021 - 2033 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. siRNA Chemical, Linkers & Reagents Market: Application Movement Analysis
• 5.2. Therapeutics Development
  • 5.2.1. Therapeutics Development Market, 2021 - 2033 (USD Million)
• 5.3. Research & Discovery
  • 5.3.1. Research & Discovery Market, 2021 - 2033 (USD Million)
• 5.4. Drug Delivery Platform Development
  • 5.4.1. Drug Delivery Platform Development Market, 2021 - 2033 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End use Business Analysis

• 6.1. siRNA Chemical, Linkers & Reagents Market: End use Movement Analysis
• 6.2. Pharmaceutical & Biotechnology Companies
  • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
• 6.3. CMOs / CDMOs
  • 6.3.1. CMOs / CDMOs Market, 2021 - 2033 (USD Million)
• 6.4. Academic & Research Institutes
  • 6.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. siRNA Chemical, Linkers & Reagents Market Share By Region, 2025 & 2033
• 7.2. North America
  • 7.2.1. North America siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. U.S. siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Canada siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Regulatory Framework
    • 7.2.4.4. Mexico siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. UK siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Germany siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. France siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Italy siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Spain siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Denmark siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Sweden siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Norway siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Japan siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. China siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. India siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Australia siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Thailand siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. South Korea siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Brazil siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Argentina siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. South Africa siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Saudi Arabia siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. UAE siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Kuwait siRNA Chemical, Linkers & Reagents Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Position / Share Analysis, 2025
• 8.4. Company Profiles
  • 8.4.1. Thermo Fisher Scientific
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Agilent Technologies
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Danaher Corporation
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Bachem
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. LGC Biosearch Technologies
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. WuXi AppTec
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Nitto Denko Avecia
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Bio-Synthesis
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Maravai LifeSciences
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. ChemGenes Corporation
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives
  • 8.4.12. Glen Research
    • 8.4.12.1. Overview
    • 8.4.12.2. Financial Performance
    • 8.4.12.3. Product Benchmarking
    • 8.4.12.4. Strategic Initiatives